A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma

NCT01310816 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Conventional Chondrosarcoma

Interventions

DRUG: IPI-926
DRUG: Placebo Arm

Sponsor

Infinity Pharmaceuticals, Inc.